ArticleBMC gastroenterology2024

Evaluating vonoprazan and tegoprazan for gastroesophageal reflux disease treatment in Chinese Healthcare: an EVIDEM framework analysis.

Chaojun Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.